MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
CERT Certara
- 10.710
- +0.160+1.52%
Close Dec 20 16:00 ET
- 10.710
- 0.0000.00%
Post 20:01 ET
1.72BMarket Cap-53.55P/E (TTM)
11.050High10.510Low3.24MVolume10.540Open10.550Pre Close34.77MTurnover2.93%Turnover RatioLossP/E (Static)160.99MShares19.87052wk High1.64P/B1.19BFloat Cap9.41052wk Low--Dividend TTM110.77MShs Float45.480Historical High--Div YieldTTM5.12%Amplitude9.410Historical Low10.729Avg Price1Lot Size
About Certara Company
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Company Profile
SymbolCERT
Company NameCertara
Listing DateDec 11, 2020
Issue Price23.00
Founded2017
CEODr. William F. Feehery, PhD
MarketNASDAQ
Employees1391
Fiscal Year Ends12-31
Address4 Radnor Corporate Center,Suite 350
CityRadnor
ProvincePennsylvania
CountryUnited States of America
Zip Code19087
Phone1-415-237-8772
Websitehttp://www.certara.com
Company Executives
- Name
- Position
- Salary
- Dr. William F. Feehery, PhD
- Director and Chief Executive Officer
- 7.81M
- Nicolette D. Sherman
- Chief Human Resources Officer
- --
- John E. Gallagher
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 4.24M
- Leif E. Pedersen
- President and Chief Commercial Officer
- 2.14M
- Richard M. Traynor
- Senior Vice President and General Counsel
- --
- Dr. Robert Aspbury, PhD
- President, Certara Scientific Software
- 2.09M
- Patrick F Smith
- President, Integrated Drug Development
- 2.42M
- James E. Cashman, III
- Chairman of the Board
- 319.51K
- Dr. John V. W. Reynders
- Director
- --
- Nancy Killefer
- Independent Director
- 252.01K
- Eran Broshy
- Independent Director
- 252.01K
- David Spaight
- Independent Director
- --
- Matthew M. Walsh
- Independent Director
- 252.01K
- Rosemary A. Crane, M.B.A.
- Independent Director
- 239.51K
- Cynthia Lynne Collins
- Independent Director
- 242.01K
- Stephen M. McLean
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.